Qiagen (QGEN) Net Income towards Common Stockholders Growth (1y) (2010 - 2025)
Qiagen (QGEN) Net Income towards Common Stockholders Growth (1y) (2010 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn | 8.66% |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn | 56.76% |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn | 15.11% |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn | 57.67% |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn | -9.74% |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn | -27.15% |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn | -11.91% |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn | 15.10% |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn | 12.89% |
| 10 | Qiagen | 8.64 Bn | 8.64 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.31% |
| Sep 30, 2025 | 32.62% |
| Jun 30, 2025 | 7.32% |
| Mar 31, 2025 | 16.35% |
| Dec 31, 2024 | 2.94% |
| Sep 30, 2024 | 26.01% |
| Jun 30, 2024 | 52.25% |
| Mar 31, 2024 | 22.30% |
| Dec 31, 2023 | 290.98% |
| Sep 30, 2023 | -5.55% |
| Jun 30, 2023 | -31.54% |
| Mar 31, 2023 | -53.79% |
| Dec 31, 2022 | -80.13% |
| Jun 30, 2022 | -23.87% |
| Mar 31, 2022 | 19.48% |
| Dec 31, 2021 | 188.69% |
| Jun 30, 2021 | 72.68% |
| Mar 31, 2021 | 286.65% |
| Dec 31, 2020 | -4.54% |
| Sep 30, 2020 | 63.07% |